Dataset Information

An Ensemble Learning Strategy for Eligibility Criteria Text Classification for Clinical Trial Recruitment: Algorithm Development and Validation.

ABSTRACT: BACKGROUND:Eligibility criteria are the main strategy for screening appropriate participants for clinical trials. Automatic analysis of clinical trial eligibility criteria by digital screening, leveraging natural language processing techniques, can improve recruitment efficiency and reduce the costs involved in promoting clinical research. OBJECTIVE:We aimed to create a natural language processing model to automatically classify clinical trial eligibility criteria. METHODS:We proposed a classifier for short text eligibility criteria based on ensemble learning, where a set of pretrained models was integrated. The pretrained models included state-of-the-art deep learning methods for training and classification, including Bidirectional Encoder Representations from Transformers (BERT), XLNet, and A Robustly Optimized BERT Pretraining Approach (RoBERTa). The classification results by the integrated models were combined as new features for training a Light Gradient Boosting Machine (LightGBM) model for eligibility criteria classification. RESULTS:Our proposed method obtained an accuracy of 0.846, a precision of 0.803, and a recall of 0.817 on a standard data set from a shared task of an international conference. The macro F1 value was 0.807, outperforming the state-of-the-art baseline methods on the shared task. CONCLUSIONS:We designed a model for screening short text classification criteria for clinical trials based on multimodel ensemble learning. Through experiments, we concluded that performance was improved significantly with a model ensemble compared to a single model. The introduction of focal loss could reduce the impact of class imbalance to achieve better performance.

SUBMITTER: Zeng K

PROVIDER: S-EPMC7367522 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

An Ensemble Learning Strategy for Eligibility Criteria Text Classification for Clinical Trial Recruitment: Algorithm Development and Validation.

Zeng Kun K Pan Zhiwei Z Xu Yibin Y Qu Yingying Y

JMIR medical informatics 20200701 7

<h4>Background</h4>Eligibility criteria are the main strategy for screening appropriate participants for clinical trials. Automatic analysis of clinical trial eligibility criteria by digital screening, leveraging natural language processing techniques, can improve recruitment efficiency and reduce the costs involved in promoting clinical research.<h4>Objective</h4>We aimed to create a natural language processing model to automatically classify clinical trial eligibility criteria.<h4>Methods</h4> ...[more]

PMID: 32609092

Similar Datasets

Project description:ObjectiveEfficiently identifying eligible patients is a crucial first step for a successful clinical trial. The objective of this study was to test whether an approach using electronic health record (EHR) data and an ensemble machine learning algorithm incorporating billing codes and data from clinical notes processed by natural language processing (NLP) can improve the efficiency of eligibility screening.MethodsWe studied patients screened for a clinical trial of rheumatoid arthritis (RA) with one or more International Classification of Diseases (ICD) code for RA and age greater than 35 years, from a tertiary care center and a community hospital. The following three groups of EHR features were considered for the algorithm: 1) structured features, 2) the counts of NLP concepts from notes, 3) health care utilization. All features were linked to dates. We applied random forest and logistic regression with least absolute shrinkage and selection operator penalty against the following two standard approaches: 1) one or more RA ICD code and no ICD codes related to exclusion criteria (ScreenRAICD1 +EX ) and 2) two or more RA ICD codes (ScreenRAICD2 ). To test the portability, we trained the algorithm at one institution and tested it at the other.ResultsIn total, 3359 patients at Brigham and Women's Hospital (BWH) and 642 patients at Faulkner Hospital (FH) were studied, with 461 (13.7%) eligible patients at BWH and 84 (13.4%) at FH. The application of the algorithm reduced ineligible patients from chart review by 40.5% at the tertiary care center and by 57.0% at the community hospital. In contrast, ScreenRAICD2 reduced patients for chart review by 2.7% to 11.3%; ScreenRAICD1+EX reduced patients for chart review by 63% to 65% but excluded 22% to 27% of eligible patients.ConclusionThe ensemble machine learning algorithm incorporating billing codes and NLP data increased the efficiency of eligibility screening by reducing the number of patients requiring chart review while not excluding eligible patients. Moreover, this approach can be trained at one institution and applied at another for multicenter clinical trials.

Project description:A novel coronavirus (COVID-19) has globally attracted attention as a severe respiratory condition. The epidemic has been first tracked in Wuhan, China, and has progressively been expanded in the entire world. The growing expansion of COVID-19 around the globe has made X-ray images crucial for accelerated diagnostics. Therefore, an effective computerized system must be established as a matter of urgency, to facilitate health care professionals in recognizing X-ray images from COVID-19 patients. In this work, we design a novel artificial intelligent-based automated X-ray image analysis framework based on an ensemble of deep optimized convolutional neural networks (CNNs) in order to distinguish coronavirus patients from non-patients. By developing a modified version of gaining-sharing knowledge (GSK) optimization algorithm using the Opposition-based learning (OBL) and Cauchy mutation operators, the architectures of the deployed deep CNNs are optimized automatically without performing the general trial and error procedures. After obtaining the optimized CNNs, it is also very critical to identify how to decrease the number of ensemble deep CNN classifiers to ensure the classification effectiveness. To this end, a selective ensemble approach is proposed for COVID-19 X-ray based image classification using a deep Q network that combines reinforcement learning (RL) with the optimized CNNs. This approach increases the model performance in particular and therefore decreases the ensemble size of classifiers. The experimental results show that the proposed deep RL optimized ensemble approach has an excellent performance over two popular X-ray image based COVID-19 datasets. Our proposed advanced algorithm can accurately identify the COVID-19 patients from the normal individuals with a significant accuracy of 0.991441, precision of 0.993568, recall (sensitivity) of 0.981445, F-measure of 0.989666 and AUC of 0.990337 for Kaggle dataset as well as an excellent accuracy of 0.987742, precision of 0.984334, recall (sensitivity) of 0.989123, F-measure of 0.984939 and AUC of 0.988466 for Mendely dataset.

Project description:Accurate diagnostic discrimination of benign renal oncocytoma (OC) and malignant renal cell carcinomas (RCC) is not only useful for planning appropriate treatment strategies of patients with renal masses but also for estimating prognosis. Classification of renal neoplasms solely by histopathology can often be challenging for a variety of reasons. The aim of this study was to develop and validate a genomic algorithm for molecular classification of renal cortical neoplasms that could be implemented in a routine clinical diagnostic setting. Using TCGA (The Cancer Genome Atlas) copy number profiles of over 600 RCC specimens, prior FISH studies and published literature, a classification algorithm was developed consisting of 15 genomic markers: loss of VHL, 3p21, 8p, and chromosomes 1, 2, 6, 10 and 17, and gain of 5qter, 16p, 17q, 20q, and chromosomes 3, 7, and 12. Criteria for scoring specimens for the presence of each genomic marker were established. As validation, 191 surgically resected formalin-fixed paraffin-embedded renal neoplasms were blindly submitted to targeted array-CGH and were classified according to the algorithm. Upon histologic re-review leading to exclusion of three specimens and using histology as the gold standard, the algorithm correctly classified 58 of 62 (93%) clear cell renal cell carcinoma, 51 of 56 (91%) papillary RCC, and 33 of 34 (97%) chromophobe RCC. Of the 36 OC specimens, 17 were classified as OC, two as a malignant subtype, 14 as benign, and three exhibited alterations not associated with a specific subtype. In ten of the latter two groups, CCND1-rearrangement was detected by fluorescence in situ hybridization, affording a classification as OC. Together, 33 of 36 (92%) OC were classified as OC or benign. For the entire validation cohort, an overall diagnostic sensitivity of 93% and above 97% specificity was achieved, suggesting that the implementation of genome-based molecular classification in a clinical diagnostic setting could impact the overall management and outcome of patients with renal tumors.

Project description:In recent years, the number of vulnerabilities discovered and publicly disclosed has shown a sharp upward trend. However, the value of exploitation of vulnerabilities varies for attackers, considering that only a small fraction of vulnerabilities are exploited. Therefore, the realization of quick exclusion of the non-exploitable vulnerabilities and optimal patch prioritization on limited resources has become imperative for organizations. Recent works using machine learning techniques predict exploited vulnerabilities by extracting features from open-source intelligence (OSINT). However, in the face of explosive growth of vulnerability information, there is room for improvement in the application of past methods to multiple threat intelligence. A more general method is needed to deal with various threat intelligence sources. Moreover, in previous methods, traditional text processing methods were used to deal with vulnerability related descriptions, which only grasped the static statistical characteristics but ignored the context and the meaning of the words of the text. To address these challenges, we propose an exploit prediction model, which is based on a combination of fastText and LightGBM algorithm and called fastEmbed. We replicate key portions of the state-of-the-art work of exploit prediction and use them as benchmark models. Our model outperforms the baseline model whether in terms of the generalization ability or the prediction ability without temporal intermixing with an average overall improvement of 6.283% by learning the embedding of vulnerability-related text on extremely imbalanced data sets. Besides, in terms of predicting the exploits in the wild, our model also outperforms the baseline model with an F1 measure of 0.586 on the minority class (33.577% improvement over the work using features from darkweb/deepweb). The results demonstrate that the model can improve the ability to describe the exploitability of vulnerabilities and predict exploits in the wild effectively.

Dataset Information

An Ensemble Learning Strategy for Eligibility Criteria Text Classification for Clinical Trial Recruitment: Algorithm Development and Validation.

Publications

An Ensemble Learning Strategy for Eligibility Criteria Text Classification for Clinical Trial Recruitment: Algorithm Development and Validation.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure